China SXT Pharmaceuticals Inc (SXTC) — Cash Flow Quality Index
China SXT Pharmaceuticals Inc (SXTC) has a Cash Flow Quality Index of -0.20x as of December 2023. Operating cash flow of $-674.24K is below net income of $3.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of China SXT Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China SXT Pharmaceuticals Inc Cash Flow Quality Index (2016–2019)
Historical Cash Flow Quality Index for China SXT Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check China SXT Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for China SXT Pharmaceuticals Inc (2016–2019)
Year-by-year earnings quality comparison for China SXT Pharmaceuticals Inc. For live market cap and the full company financial profile, see SXTC company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.16x | $239.19K | $1.54 Million | ▼ -90.4% |
| 2018 | 1.62x | $1.92 Million | $1.19 Million | ▲ +553.9% |
| 2017 | 0.25x | $293.04K | $1.19 Million | ▼ -80.8% |
| 2016 | 1.29x | $182.47K | $141.54K | — |